Saudi Pharmaceutical Industries and Medical Appliances Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Saudi Pharmaceutical Industries and Medical Appliances heeft een totaal eigen vermogen van SAR1.6B en een totale schuld van SAR1.6B, wat de schuld-eigenvermogensverhouding op 96% brengt. De totale activa en totale passiva bedragen respectievelijk SAR4.5B en SAR2.8B. De EBIT Saudi Pharmaceutical Industries and Medical Appliances is SAR114.0M waardoor de rentedekking 1.9 is. Het heeft contanten en kortetermijnbeleggingen van SAR340.2M.
Belangrijke informatie
96.0%
Verhouding schuld/eigen vermogen
ر.س1.56b
Schuld
| Rente dekkingsratio | 1.9x |
| Contant | ر.س340.21m |
| Aandelen | ر.س1.63b |
| Totaal verplichtingen | ر.س2.84b |
| Totaal activa | ر.س4.47b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations
Nov 24
Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump
Sep 05Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing
Mar 21Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?
Jun 26Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?
Mar 14Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price
Aug 02Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60
May 19One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates
May 12A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Feb 20Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 18Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?
Mar 30Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?
Feb 23What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition
Jan 19
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?
Dec 16Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( SAR2.5B ) 2070 } overtreffen de korte termijn passiva ( SAR2.0B ).
Langlopende schulden: De kortetermijnactiva 2070 ( SAR2.5B ) overtreffen de langetermijnschulden ( SAR841.4M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 75% ) 2070 wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van 2070 is de afgelopen 5 jaar gestegen van 55.1% naar 96%.
Schuldendekking: De operationele kasstroom van 2070 is negatief, waardoor de schuld niet goed gedekt is.
Rentedekking: De rentebetalingen van 2070 op haar schulden worden niet goed gedekt door EBIT ( 1.9 x dekking).